Comprehensive Analysis of Electrochemical Biosensors for Early Ovarian Cancer Detection

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2024 Nov 26

PMID 39588243

Authors

Marwa A El-Gammal

Fatma E Sayed

Nageh K Allam

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer is one of the leading causes of mortality among women worldwide. However, early detection can significantly reduce mortality rates and mitigate subsequent complications related to both economic burden and mental well-being. Despite the development in the field of medical diagnosis, the death rates due to ovarian cancer have sharply increased. Among the recent technologies suggested as suitable diagnostic techniques for the early detection of ovarian cancer, biosensor technology has emerged as a cutting-edge technology, with electrochemical biosensors providing one of the most efficient types of biosensors. Therefore, this review discusses the application of electrochemical biosensors as a viable alternative to conventional diagnostic techniques for the timely identification of ovarian cancer, its advantages over other types of biosensors and conventional diagnostic techniques, and the types of electrochemical biosensors.

References

Allegra A, Petrarca C, Di Gioacchino M, Mirabile G, Gangemi S . Electrochemical Biosensors in the Diagnosis of Acute and Chronic Leukemias. Cancers (Basel). 2023; 15(1). PMC: 9817807. DOI: 10.3390/cancers15010146. View

Mohamed M, Hasan M, Abdullah I, Abdellah A, Yehia A, Ahmed N . Smart bi-metallic perovskite nanofibers as selective and reusable sensors of nano-level concentrations of non-steroidal anti-inflammatory drugs. Talanta. 2018; 185:344-351. DOI: 10.1016/j.talanta.2018.03.104. View

Navya P, Daima H . Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives. Nano Converg. 2017; 3(1):1. PMC: 5271116. DOI: 10.1186/s40580-016-0064-z. View

Asl E, Sarabandi S, Shademan B, Dalvandi K, Sheikhansari G, Nourazarian A . MicroRNA targeting: A novel therapeutic intervention for ovarian cancer. Biochem Biophys Rep. 2023; 35:101519. PMC: 10382632. DOI: 10.1016/j.bbrep.2023.101519. View

Poon M, Keni S, Vimalan V, Ip C, Smith C, Erridge S . Extent of promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study. Neurooncol Adv. 2022; 3(1):vdab171. PMC: 8704383. DOI: 10.1093/noajnl/vdab171. View

Mitra A, Zillhardt M, Hua Y, Tiwari P, Murmann A, Peter M . MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov. 2012; 2(12):1100-8. PMC: 3685866. DOI: 10.1158/2159-8290.CD-12-0206. View

Hayrapetyan H, Tran T, Tellez-Corrales E, Madiraju C . Enzyme-Linked Immunosorbent Assay: Types and Applications. Methods Mol Biol. 2023; 2612:1-17. DOI: 10.1007/978-1-0716-2903-1_1. View

Mohamed M, El-Gendy D, Ahmed N, Banks C, Allam N . 3D spongy graphene-modified screen-printed sensors for the voltammetric determination of the narcotic drug codeine. Biosens Bioelectron. 2017; 101:90-95. DOI: 10.1016/j.bios.2017.10.020. View

Mu W, Wu C, Wu F, Gao H, Ren X, Feng J . Ultrasensitive and label-free electrochemical immunosensor for the detection of the ovarian cancer biomarker CA125 based on CuCo-ONSs@AuNPs nanocomposites. J Pharm Biomed Anal. 2024; 243:116080. DOI: 10.1016/j.jpba.2024.116080. View

10.

Chen D, Jiang L, Zhang J, Tang C, Wang A, Feng J . Electrochemical label-free immunoassay of HE4 using 3D PtNi nanocubes assemblies as biosensing interfaces. Mikrochim Acta. 2022; 189(12):455. DOI: 10.1007/s00604-022-05553-6. View

11.

Park J, Lee G, Song Z, Bong J, Chang Y, Cho S . Capacitive biosensor based on vertically paired electrodes for the detection of SARS-CoV-2. Biosens Bioelectron. 2022; 202:113975. PMC: 8741629. DOI: 10.1016/j.bios.2022.113975. View

12.

Alshamrani A . Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?. Front Oncol. 2020; 10:1084. PMC: 7396563. DOI: 10.3389/fonc.2020.01084. View

13.

Parkash J, Bansro V, Chhabra G, Mujahid Z . Almost a Near Miss: Hairy Cell Leukemia. Cureus. 2023; 15(1):e33949. PMC: 9938344. DOI: 10.7759/cureus.33949. View

14.

Fatima B, Hussain D, Bashir S, Hussain H, Aslam R, Nawaz R . Catalase immobilized antimonene quantum dots used as an electrochemical biosensor for quantitative determination of HO from CA-125 diagnosed ovarian cancer samples. Mater Sci Eng C Mater Biol Appl. 2020; 117:111296. DOI: 10.1016/j.msec.2020.111296. View

15.

Cotchim S, Thavarungkul P, Kanatharana P, Thantipwan T, Jiraseree-Amornkun A, Wannapob R . A portable electrochemical immunosensor for ovarian cancer uses hierarchical microporous carbon material from waste coffee grounds. Mikrochim Acta. 2023; 190(6):232. DOI: 10.1007/s00604-023-05798-9. View

16.

Dilley J, Burnell M, Gentry-Maharaj A, Ryan A, Neophytou C, Apostolidou S . Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Gynecol Oncol. 2020; 158(2):316-322. PMC: 7453382. DOI: 10.1016/j.ygyno.2020.05.002. View

17.

Kim S, Jung M, Dan K, Lee S, Lee C, Kim H . Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma. Cancers (Basel). 2020; 12(4). PMC: 7226362. DOI: 10.3390/cancers12040790. View

18.

Azhar Hayat Nawaz M, Hassan Akhtar M, Ren J, Akhtar N, Hayat A, Yu C . Black phosphorus nanosheets/poly(allylamine hydrochloride) based electrochemical immunosensor for the selective detection of human epididymis protein 4. Nanotechnology. 2022; 33(48). DOI: 10.1088/1361-6528/ac8bd8. View

19.

Sakamoto S, Putalun W, Vimolmangkang S, Phoolcharoen W, Shoyama Y, Tanaka H . Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. J Nat Med. 2017; 72(1):32-42. PMC: 5775980. DOI: 10.1007/s11418-017-1144-z. View

20.

Moazampour M, Zare H, Shekari Z . Femtomolar determination of an ovarian cancer biomarker (miR-200a) in blood plasma using a label free electrochemical biosensor based on L-cysteine functionalized ZnS quantum dots. Anal Methods. 2021; 13(17):2021-2029. DOI: 10.1039/d1ay00330e. View